He woke to find his maid unconscious beside him, a half-used syringe resting against his paralyzed leg. He thought she came to kill him—until the label revealed a secret experiment tied to the bullet that put him in the wheelchair.

Dominic Vale did not call back, and that frightened Danny more than any threat could have. Powerful men shouted when they wanted to be feared. Men who already believed they had won tended to become quiet. By dawn, three of Dominic’s board representatives had resigned from Russo Maritime, a logistics company Danny used to keep the legitimate side of his empire visible and respectable. Two banks suddenly requested compliance reviews. A federal tax inquiry that had been dormant for months became active again.

“He’s closing doors around you,” Luke said during breakfast. “Financial, legal, political.” Danny looked out at the lake. “Then we stop playing defense.”

Emma sat across from him, studying Claire’s notebook. She had barely slept. Vance had insisted she take a carefully measured microdose of N-14 under observation, and the tremor in her hands had eased. “My mother marked one location three times,” she said. “The old Halcyon research annex in South Deering. It was supposed to be demolished, but the city database shows the parcel is still privately owned.”

Luke checked his tablet. “Owner is another Marrow subsidiary.” Danny smiled faintly. “Of course it is.”

They went that afternoon.

The facility sat behind a chain-link fence near abandoned industrial lots where weeds grew through cracked asphalt and freight trains moved like dark animals beyond concrete walls. From the outside, the building looked dead. Inside, it was not. Luke found a fresh electronic lock beneath a rusted steel plate. Someone had wanted the place to look abandoned while keeping it usable.

The main laboratory had been stripped, but a hidden sublevel still had power. Fluorescent lights flickered on above rows of glass rooms and stainless-steel cabinets. Emma stopped in the corridor. “I remember this.” Her voice became smaller. “They told me the basement was storage. My mother brought me through that door after hours.”

Vance discovered an active refrigeration unit. Inside were sealed cartridges, blood samples, and labeled tissue cultures. Some bore recent dates. One name appeared repeatedly on the inventory: E. Carter. Emma leaned against the counter as if struck. “They’ve been tracking me.”

Danny’s anger came cold now, without explosion. “How?”

Vance scanned the entries. “These samples could have come from the clinic. Every time you thought you were buying medication, they may have been collecting blood.” Emma’s face twisted with disgust. “I was paying them to experiment on me.”

Luke called from the adjoining office. “You need to see this.”

A wall monitor activated when he connected a recovered drive. Security footage filled the screen. The date was two years earlier, the night Danny had been shot. The camera angle showed a private hospital corridor. Danny recognized the location immediately. He had been moved there after emergency surgery, still unconscious, with police outside the floor.

At 2:14 a.m., a nurse entered his room.

Vance stepped closer. “I don’t know her.”

The nurse remained inside for four minutes. When she emerged, Dominic Vale followed.

Nobody spoke.

The next clip was not video but an internal memo. TRAUMA SUBJECT D.R. received post-lesion inhibitor N-9 within target window. Neurological suppression stable. Regenerative candidacy preserved. Authorization: D.V.

Danny read it twice. He did not need anyone to interpret the initials.

Emma stood beside him. “He didn’t want you dead.”

“No.” Danny’s fingers tightened around the armrest. “He wanted me available.”

“For what?” Luke asked.

Vance answered. “A human proof-of-concept. N-14 had failed in degenerative patients because their nerves were dying everywhere at once. A traumatic spinal injury is localized. If they could first suppress recovery and later restart it, they could prove controlled regeneration.” He looked sick. “Danny wasn’t a patient. He was a demonstration.”

Something broke loose inside Danny then, but it was not rage. Rage was too simple. This was grief for every morning he had woken believing his body had betrayed him. Every physical therapy session in which he had pushed until his hands bled. Every night he had refused help because dependence felt like humiliation. Dominic had been at his bedside for all of it.

Emma placed one hand over Danny’s clenched fist.

The touch grounded him.

Luke continued searching files and found another folder protected by an old encryption key. Claire’s notebook contained a sequence that opened it. Inside were correspondence records between Halcyon researchers and Marrow Capital. Claire had discovered that the fatal Phase II incidents were not random dosage errors. Executives had intentionally changed the stabilizer to create catastrophic failures in a subset of subjects. The deaths gave them justification to bury the public trial while transferring the most valuable patents into private ownership.

“They killed the program so they could own it in secret,” Emma whispered.

“Not just the program,” Vance said. He pointed to an attachment listing patient heirs. “They also gained control over every biological sample, every genetic sequence, every discovery tied to the trial.”

Emma stared at her own name.

A door slammed upstairs.

Luke killed the monitor. “We have company.”

This time the men did not ask politely.

Gunfire cracked through the upper floor, followed by the sound of glass breaking. Luke shoved a steel cabinet against the stairwell door and called his security team. Danny hated the familiar helplessness that rose in him as movement became a calculation. Emma saw it and crouched beside his chair.

“There’s another exit,” she said. “My mother used it.”

She led them through a lab freezer into a narrow service corridor. Halfway down, Danny’s chair struck a raised pipe and stopped. Luke tried to lift the frame, but more shots sounded behind them. “Go,” Danny ordered. “I can hold the corridor.” Emma turned on him. “No.”

“Emma.”

“I said no.”

She dropped to her knees, used a length of metal as leverage, and helped Luke lift the front wheels over the obstruction. A spasm hit her mid-motion. Her face contorted, but she did not release the bar until Danny was clear. They reached the loading bay seconds before Luke’s backup crashed through the outer gate.

No one chased them farther.

Back in the vehicle, Emma was shaking from pain. Danny took her hand without thinking. She looked at him, surprised, then closed her fingers around his.

Vance sat opposite them holding one recovered cartridge of N-14.

“I can make a safer formulation,” he said. “Claire’s notes include the original stabilizer ratio. It won’t be a cure, and I cannot promise what it will do to either of you. But I believe I can stop Emma’s deterioration.”

Danny looked at the cartridge.

“And me?”

Vance held his gaze. “Theoretically, your pathways are not dead. They are suppressed and scarred. If N-9 did what these records say, N-14 might restore some function.”

Hope entered the vehicle like a third threat.

Danny looked down at his legs.

Then at Emma.

“How dangerous?”

Vance did not lie. “Very.”

Danny nodded once.

“Then we do it right.”

Outside, the abandoned Halcyon building receded behind them.

On its rooftop, unseen by the departing convoy, a man in a dark coat stood behind broken glass and raised a phone.

“Vale,” he said when the call connected. “Russo has the formula.”

A pause.

“And the girl?”